HIV+

Kaposi's sarcoma treatment in Kenya and Nigeria

  • Principal Investigator(s): Esther Freeman
  • Study Contact: efreeman@mgh.harvard.edu
  • Description of Subjects: Adults with HIV-related Kaposi's sarcoma in Kenya and Nigeria
  • Location (Domestic vs. International): AMPATH (Eldoret, Kenya), Institute of Human Virology (Abuja, Nigeria)
  • Enrollment Period: 2009-2012
  • Enrollment Goal: All KS patients diagnosed at these sites during enrollment period

HIV Research Network (HIVRN)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Sarah Wolfrum, DrPH, 617-927-6367, swolfrum@fenwayhealth.org
  • Description of Subjects: HIV-infected patients aged 18 and older receiving medical care at Fenway Health. (HIVRN includes pediatric data, but Fenway Health only submits adult patient data)
    • HIV+
    • HIV/HCV Co-infected

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin617.724.3194rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

HIV-associated Seizures and Epilepsy in Zambia

  • Principal Investigator(s): Omar K. Siddiqi
  • Study Contact: Omar K. Siddiqi, +260 979365956, osiddiqi@bidmc.harvard.edu
  • Description of Subjects: HIV+ adults with new onset seizure
  • Location (Domestic vs. International): Lusaka, Zambia - University of Zambia School of Medicine
  • Enrollment Period: 2011 - 2013
  • Enrollment Goal: 100

CFAR Network of Integrated Clinical Systems (C-NICS)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Chris Grasso, Tel: 617-927-6018, cgrasso@fenwayhealth.org
  • Description of Subjects: HIV infected patients receiving primary care at Fenway Health. HIV+, HIV Co-infected
  • Location (Domestic vs. International): Fenway Health: Boston, MA
  • Enrollment Period: 1997 to present (ongoing)

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014

HIV and Aging Cohort Study

  • Principal Investigator(s): Nina Lin
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
  • Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
  • Enrollment Period: 2011-present
  • Enrollment Goal: